The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study
Sengupta N, Feuerstein J, Patwardhan V, Tapper E, Ketwaroo G, Thaker A, Leffler D. The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study. The American Journal Of Gastroenterology 2014, 110: 328. PMID: 25512338, DOI: 10.1038/ajg.2014.398.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAnticoagulantsBenzimidazolesBeta-AlanineCohort StudiesDabigatranEnoxaparinFemaleGastrointestinal HemorrhageHeparinHumansIschemic Attack, TransientLongitudinal StudiesMaleMiddle AgedMorpholinesPatient ReadmissionProspective StudiesPulmonary EmbolismPyrazolesPyridonesRecurrenceRivaroxabanStrokeThiophenesThromboembolismVenous ThrombosisWarfarinWithholding TreatmentConceptsRecurrent gastrointestinal bleedingGastrointestinal bleedingSystemic anticoagulationAnticoagulation continuationThromboembolic eventsThrombotic eventsEtiology of GIBProspective observational cohort studyIntensive care unit careHospital transfusion requirementsMajor thrombotic episodesRisk of continuationObservational cohort studyRisk of thromboembolismCox proportional hazardsTransfusion requirementsCohort studyHospital dischargeUnit careConsecutive patientsHospital readmissionThrombotic episodesProspective studyHospitalized inpatientsFollowing outcomes